Decoding MHC loss: Molecular mechanisms and implications for immune resistance in cancer
Abstract Loss or downregulation of major histocompatibility complex (MHC) molecules represents a key mechanism by which tumours escape immune recognition and acquire resistance to immunotherapeutic interventions. This review focuses on the central regulatory pathways. These includes transcriptional...
Saved in:
| Main Authors: | Pei Lin, Yunfan Lin, Xu Chen, Xinyuan Zhao, Li Cui |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Clinical and Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ctm2.70403 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MHC-I pathway disruption by viruses: insights into immune evasion and vaccine design for animals
by: Yanan Wu, et al.
Published: (2025-05-01) -
Editorial: Specific targeting of MHC antigens for T-cells and immune cells in human disease
by: Ali Afzal, et al.
Published: (2025-01-01) -
RECQL4 affects MHC class II‐mediated signalling and favours an immune‐evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melanoma
by: Sara Egea‐Rodriguez, et al.
Published: (2025-01-01) -
The metabolic dialogue between intratumoural microbes and cancer: implications for immunotherapy
by: Yingheng Situ, et al.
Published: (2025-05-01) -
Role of metabolic transformation in cancer immunotherapy resistance: molecular mechanisms and therapeutic implications
by: Sandesh Shende, et al.
Published: (2025-04-01)